Sentences with phrase «per share price target»

Echelon has a Top Pick status, Speculative Buy recommendation and $ 2.75 per share price target on Immunovaccine, whose stock is currently trading at $ 1.63 per share.

Echelon has a Speculative Buy rating and a CA$ 3.25 per share price target on Immunovaccine Inc., whose stock is currently trading at around CA$ 2.24 per share.

Echelon has a Speculative Buy rating and a CA$ 3 per share price target on Nemaska Lithium.

Not exact matches

On Oct. 24, Twitter set its IPO price target at $ 17 to $ 20 per share.

Richards's target price for RIM is $ 72, or, as he points out just «10 times this year's earnings per share,» a valuation he calls «ridiculous.»

He also has a 12 - month price target of $ 38 per share; BHP is currently trading at about $ 31.

He upgraded his 12 - month price target from $ 55 to $ 56 on Sept. 2 and revised the company's 2014 earnings per share from $ 3.17 to $ 3.56.

Barclays has cut its rating on the budget fashion retailer to «equal weight» from «overweight» and lowered its target price on the stock to 250 Swedish crowns ($ 37.97) per share from 285 crowns.

• Aconex Ltd (ASX: ACX) received a A$ 1.56 billion ($ 1.2 billion), or A$ 7.80 in cash - per - share, buyout offer from Oracle Corp, sending the target's share price up 45 percent.

He raised his target price on the stock, currently trading around $ 174 per share, to $ 200 (up from $ 185).

The price target was cut to $ 55 per share.

While the $ 2.36 per share offer only implies a «small» 15 per cent takeover premium to Deutsche's $ 2.05 price target, the research team points to «recent operational risks in the hospital portfolio, the execution risks of the Northern Beaches greenfield project and our lower revenue growth outlook for the private hospital industry.»

«To illustrate the probable epilogue to the current bubble, we've calculated price targets for some of the glamour techs, based on current revenues per share, multiplied by the median price / revenue ratio over the bull market period 1991 - 1999.

RIM's volatile shares, however, have jumped as much as 10 per cent or more in recent weeks on single research notes, as analysts upgrade their price targets going into the smartphone's launch.

Piper Jaffray cut its view of Weatherford from overweight to neutral, and lowered its price target from $ 4.20 to $ 2.35 per share, citing the company's longer - than - expected turnaround and its continuing balance sheet troubles.

Analysts at Cowen called out the upside potential in offshore service provider Helix Energy Solutions (NYSE: HLX), upgrading the stock from market perform to outperform and increasing their price target from $ 8 to $ 10 per share.

The stock is followed only by a few Dutch analysts 4 of 5 analysts have a buy rating with target prices between 10 - 13 EUR per share.

If (for example) your pattern targets 150p per share but there is strong resistance / sell line at 145p per share then assume the price target is at the sell line.

It is roughly $ 75 per share now, and Morningstar gives it a price target of $ 87 per share.

In December 1999, well - known PaineWebber (now UBS) analyst Walter Piecyk assigned a $ 1,000 price target to Qualcomm based on the growth of wireless technology — after the company had already risen from $ 25 per share to more than $ 500 in the previous year.

Haywood has a Buy rating and a CA$ 2.80 per share target price on Equinox, whose stock is currently trading at around CA$ 1.10 per share.

Analyst Craig Hutchison indicated in a Feb. 23 research report that TD Securities Inc. was assuming coverage of Cobalt 27 following the Dumont royalty acquisition and increased its target price on the company to $ 17 from $ 16 per share.

The pet food company is «unlikely» to be offered a higher bid, so the analyst's revised price target is consistent with Friday's closing price — and the price tag on the deal of $ 40 per share.

Morgan Stanley cut its rating on the social - media company from overweight to equal weight, and it slashed its price target on the stock by more than 40 % to $ 16 per share.

OvaScience is currently trading at around $ 0.82 per share whereas H.C. Wainwright's target price on the company is $ 15, reflecting more than a fifteenfold potential increase.

Maxim has a rating of Buy and a 12 - month target price of $ 11 per share on Viveve, whose stock is currently trading at around $ 3.62 per share.

Northcoast Research initiated its coverage of Blue Apron with a sell rating and a price target of $ 2 per share, or more than 75 % below where the stock began the day.

MKM Partners started its coverage on the stock with a sell rating, setting a price target of $ 26 per share.

They emerged as the industry consolidators, using high levels of gearing to pay mind boggling prices for assets (in 2007, APN was the target of a bid by a private equity consortium that was blocked by a shareholder vote at $ 6.20 per share, a decision which cost them a lot.

But by the end of the year, his price target by the end of the year is only $ 22 per share, which would represent a 24 percent drop from current levels.

Echelon maintains its rating of Speculative Buy and price target of CA$ 3.25 per share.

Riyadh - Mubasher: Al - Rajhi Capital increased their target price (TP) for Yansab and SAFCO up to SAR 58 and 62 per share, respectively, and reiterated their ratings and target prices for most Saudi petrochemicals companies.

The gains were underpinned by Deutsche Bank, who predicted that the company will see it best period for more than three years and raised its target price by 35p per share to 360p.

Mr Slifirski has a target price on the stock of about $ 7.40 per share, well above the $ 2.71 the stock was fetching on Friday.

The consensus analyst price target is $ 77 per share and S&P Capital IQ has a buy rating on QCOM with a 12 month target price of $ 80.

The company's shares were up 10 per cent alone to about $ 1.58 on Wednesday after a Deutsche Bank analyst report revealed a 12 - month price target of $ 2.40.

The market clearly believes Saputo will win more than 75 per cent of the target because at that price the Canadians will offer $ 9.40 a share.

UBS maintained its «neutral» on Metcash with a 12 - month price target of $ 3.45 per share ahead of the company's half - year earnings result on December 3.

Historically, in order to ensure adequate liquidity for selling shares, the target initial price has been $ 10 per share.

Now trading around $ 47 per share, the mean analyst target price for BP over the next year of market action is $ 49.51.

Now trading around $ 86.50 per share, the mean analyst target price for Caterpillar over the next year of market action is $ 92.51.

«To illustrate the probable epilogue to the current bubble, we've calculated price targets for some of the glamour techs, based on current revenues per share, multiplied by the median price / revenue ratio over the bull market period 1991 - 1999.

Look up the strike price that is nearest your target price or the price you think the company is worth per share of stock (remember that current prices should be below your target strike price).

There are 4 analysts that cover CMP and the consensus price target is $ 99 per share.

My current Fair Value Price Target is virtually unchanged at GBP 8.08 p per share, offering an Upside Potential of 138 % from the current GBP 3.4 p share pPrice Target is virtually unchanged at GBP 8.08 p per share, offering an Upside Potential of 138 % from the current GBP 3.4 p share priceprice.

Originally, I was looking at a price target on ASCMA of between $ 40 and $ 45 per share.

My last fair value price target was $ 8.84 per share — we need to do a fresh survey.

Oh dear, yet another offensive write - up of mine: With ESCH at 330p per share (having peaked at 395p per share a couple of months earlier), I set a price target of 119p per share!

I kind of laugh when Evercore comes out with a target price of $ 2.50 per Rite Aid share, but perhaps they know a lot more than I do.

That being done, upgrading my price target (to a EUR 20.57 Fair Value per share, based on averaging Scenarios B & C) would certainly become a real possibility.